Medicenna Therapeutics News

H.C. Wainwright Maintains Medicenna Therapeutics(MDNAF.US) With Buy Rating, Maintains Target Price $2.5

Futu NewsDec 7, 2024 02:32

Bloom Burton Maintains Medicenna Therapeutics(MDNAF.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 11, 2024 16:35

Medicenna Therapeutics Corp (MDNA) Gets a Buy Rating From Bloom Burton

TipRanksNov 7, 2023 21:31

Oppenheimer Maintains Outperform on Medicenna Therapeutics, Lowers Price Target to $3

BenzingaAug 15, 2023 00:12

Medicenna Therapeutics Analyst Ratings

BenzingaAug 15, 2023 00:10

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

BenzingaAug 10, 2023 18:46

Medicenna Therapeutics Analyst Ratings

BenzingaAug 10, 2023 18:46

Medicenna Therapeutics Corp (MDNA) Gets a Buy Rating From H.C. Wainwright

TipRanksAug 10, 2023 18:20

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

BenzingaJul 31, 2023 18:16

Medicenna Therapeutics Analyst Ratings

BenzingaJul 31, 2023 18:15

H.C. Wainwright Maintains Their Buy Rating on Medicenna Therapeutics Corp (MDNA)

TipRanksJun 28, 2023 18:20

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

BenzingaJun 28, 2023 18:12

Watching Medicenna Therapeutics; Zacks Small-Cap Research Sets $7/Price Target

BenzingaApr 19, 2023 22:06

Medicenna Therapeutics Analyst Ratings

Benzinga Analyst RatingsFeb 8, 2023 19:20

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

Benzinga Real-time NewsFeb 8, 2023 19:20

Medicenna Therapeutics Analyst Ratings

Benzinga Analyst RatingsNov 29, 2022 20:56

Guggenheim Initiates Coverage On Medicenna Therapeutics With Buy Rating, Announces Price Target of C$2

Benzinga Real-time NewsNov 29, 2022 20:55

HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $2.50 From $4, Maintains Buy Rating

MT NewswiresNov 8, 2022 23:55

Medicenna Therapeutics Analyst Ratings

Benzinga Analyst RatingsNov 8, 2022 20:03